Meag Munich Ergo’s Teva Pharmaceuticals TEVA Stock Holding History

Meag Munich Ergo’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-70,000	Closed	-$526K	–	233
2022 Q2	$526K	Hold	70,000	–	–	0.03%	174
2022 Q1	$665K	Hold	70,000	–	–	0.05%	156
2021 Q4	$555K	Hold	70,000	–	–	0.04%	133
2021 Q3	$682K	Hold	70,000	–	–	0.12%	123
2021 Q2	$693K	Buy	70,000 +40,000	+133%	+$423K	0.07%	226
2021 Q1	$346K	Hold	30,000	–	–	0.03%	288
2020 Q4	$288K	Hold	30,000	–	–	0.07%	177
2020 Q3	$270K	Hold	30,000	–	–	0.05%	187
2020 Q2	$370K	Hold	30,000	–	–	0.07%	174
2020 Q1	$269K	Hold	30,000	–	–	0.06%	158
2019 Q4	$292K	Hold	30,000	–	–	0.03%	355
2019 Q3	$207K	Sell	30,000 -5,000	-14%	-$38.3K	0.01%	516
2019 Q2	$318K	Buy	35,000 +30,000	+600%	+$362K	0.02%	477
2019 Q1	$78K	Sell	5,000 -25,000	-83%	-$441K	0.01%	525
2018 Q4	$471K	Hold	30,000	–	–	0.06%	289
2018 Q3	$634K	Hold	30,000	–	–	0.04%	336
2018 Q2	$748K	Hold	30,000	–	–	0.05%	286
2018 Q1	$509K	Hold	30,000	–	–	0.02%	355
2017 Q4	$573K	Hold	30,000	–	–	0.02%	440
2017 Q3	$516K	Hold	30,000	–	–	0.02%	252
2017 Q2	$983K	Buy	+30,000	New	+$929K	0.04%	256
2014 Q1	–	Sell	-5,000	Closed	-$200K	–	243
2013 Q4	$200K	Hold	5,000	–	–	0.01%	219
2013 Q3	$189K	Hold	5,000	–	–	0.01%	214
2013 Q2	$196K	Buy	+5,000	New	+$195K	0.01%	209

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Meag Munich Ergo's TEVA Position: Q3 2022 in Review

Meag Munich Ergo sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 70,000 shares — an estimated $526K sold.

Meag Munich Ergo first reported a position in TEVA in Q2 2013 and held it in 24 quarters. The position peaked at $983K in Q2 2017. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Meag Munich Ergo reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Meag Munich Ergo sold 70,000 Teva Pharmaceuticals shares in Q3 2022, an estimated $526K.
Meag Munich Ergo first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 24 quarters.
Meag Munich Ergo's Teva Pharmaceuticals position peaked at $983K in Q2 2017.
430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Meag Munich Ergo's 13F filing for Q3 2022, filed 18 Oct 2022.